RD
Ruxandra Draghia-Akli
DELAYED 1 MONTH
EVP, Research & Development
NOVAVAX INC
Filings
2
Companies
1
Latest
Mar 2, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
NOVAVAX INC
Ruxandra Draghia-Akli
EVP, Research & Development
Option Exercise
—
26,667 sh
Mar 5 11:00 AM
Mar 3, 2026